Boutique Biotech

Boutique Biotech

Share this post

Boutique Biotech
Boutique Biotech
Modular Medical in the spotlight

Modular Medical in the spotlight

Insulin Pump Awaits FDA Approval Amidst Competitive Market Dynamics and Funding Needs

Bohdan (Bo) Khomtchouk, Ph.D.'s avatar
Bohdan (Bo) Khomtchouk, Ph.D.
Jan 22, 2024
∙ Paid

Share this post

Boutique Biotech
Boutique Biotech
Modular Medical in the spotlight
Share

Modular Medical ($MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately six months to approve devices submitted through the 510(k) process. However, that timeline greatly varies case by case. Tandem’s ($TNDM) newest insulin pump, called Mobi, took 9 months for the FDA to clear the…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Bohdan (Bo) Khomtchouk, Ph.D.
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share